Humacyte Inc Warrant
HUMAW
10 hedge funds and large institutions have $971K invested in Humacyte Inc Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.75% more ownership
Funds ownership: 0% → 0.75% (+0.75%)
5% less capital invested
Capital invested by funds: $1.02M → $971K (-$49K)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$107 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
-$171K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$12K |
| 3 |
HF
HRT Financial
New York
|
-$4.22K |
| 4 |
Morgan Stanley
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $257K | -$12K | -10,895 | -4% |
|
2
LPL Financial
San Diego,
California
| $213K | – | – | – |
|
|
LP
3
LMR Partners
London,
United Kingdom
| $163K | – | – | – |
|
|
RL
4
RPO LLC
Stamford,
Connecticut
| $98K | – | – | – |
|
|
5
Jane Street
New York
| $63K | +$107 | +97 | +0.2% |
|
|
SCM
6
Sio Capital Management
New York
| $58K | – | – | – |
|
|
HF
7
HRT Financial
New York
| $49K | -$4.22K | -3,825 | -8% |
|
|
ETH
8
Exos TFP Holdings
New York
| $30K | +$30K | +27,151 | New |
|
|
PSAMP
9
P. Schoenfeld Asset Management (PSAM)
New York
| $22K | – | – | – |
|
10
Verition Fund Management
Greenwich,
Connecticut
| $18K | – | – | – |
|
|
JAIC
11
Josh Arnold Investment Consultant
Edina,
Minnesota
| – | -$171K | -194,718 | Closed |
|
|
12
Morgan Stanley
New York
| – | -$1K | -600 | Closed |
|
HUMAW Hedge Fund Activity: Q3 2022 in Review
10 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q3 2022, worth a combined $971K — down 4.8% from $1.02M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of HUMAW and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $107. The largest seller was Josh Arnold Investment Consultant, exiting entirely with an estimated $171K sold.
- 10 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q3 2022, down from 12 in Q2 2022.
- Funds reported $971K of Humacyte Inc Warrant stock for Q3 2022, down 4.8% quarter-over-quarter.
- 1 fund opened new Humacyte Inc Warrant positions in Q3 2022 and 2 closed out, a net change of -1 holder.
- The largest Humacyte Inc Warrant buyer in Q3 2022 was Jane Street, an estimated $107 added.
- The largest Humacyte Inc Warrant seller in Q3 2022 was Josh Arnold Investment Consultant, an estimated $171K sold.
Based on aggregated 13F filings for Q3 2022.